Form 4: IRADIMED CORP Director Monty K. Allen Sells Shares

Director Monty K. Allen of IRADIMED CORP sold 1,947 shares of common stock at a weighted average price of $43.3654 on June 3, 2024.

Summary

• On June 3, 2024, Monty K. Allen, a director of IRADIMED CORP, sold 1,947 shares of the company's common stock.
• The sale was executed in multiple trades with prices ranging from $43.17 to $43.37 per share.
• The weighted average sale price was $43.3654.
• Following the transaction, Allen directly owns 18,053 shares of IRADIMED CORP common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a transaction by a company insider. It doesn't inherently convey positive or negative sentiment, but rather reports a factual event.

Industry Context

This is a routine disclosure of a transaction by a company insider. It's common for directors and officers to buy and sell shares of their company's stock.

Stakeholder Impact

• The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the director's reasons for selling.

Key Dates